FDA — authorised 20 December 2019
- Application: BLA761062
- Marketing authorisation holder: AMGEN INC
- Indication: Labeling
- Status: approved
🇺🇸 EVENITY in United States
FDA authorised EVENITY on 20 December 2019
Marketing authorisation
EVENITY in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is EVENITY approved in United States?
Yes. FDA authorised it on 20 December 2019.
Who is the marketing authorisation holder for EVENITY in United States?
AMGEN INC holds the US marketing authorisation.